Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Coagulation factors and hemostatic agents].

V Deneys1, C Hermans

  • 1Laboratoire d'Hémostase, Cliniques Universitaires Saint-Luc. deneys@sang.ucl.ac.be

Journal De Pharmacie De Belgique
|May 8, 2004
PubMed
Summary

Clinicians can choose from many drugs to prevent or treat bleeding. A rational approach requires identifying the cause of bleeding and considering medication costs for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns.

Cancer immunology, immunotherapy : CII·2026
Same author

Which is the best storage temperature to preserve the haemostatic quality of non-leukoreduced whole blood units collected under a military emergency protocol - Cold or room temperature?

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2025
Same author

When do benefits turn to risks? Impact of a 900 mL whole blood donation on Special Forces performance.

Transfusion·2024
Same author

Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso.

Immunohematology·2024
Same author

Hereditary angioedema (HAE) in Belgium: results from a national survey.

Frontiers in allergy·2023
Same author

Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care.

Acta clinica Belgica·2023

Area of Science:

  • Pharmacology
  • Hematology
  • Clinical Therapeutics

Context:

  • Numerous therapeutic agents exist for preventing or treating hemorrhagic events.
  • Effective management necessitates an etiological approach to guide drug selection.

Purpose:

  • To emphasize the importance of etiological diagnosis in the rational use of antithrombotic and hemostatic agents.
  • To highlight the need for cost-effectiveness analysis in prescribing medications for hemorrhagic conditions.

Summary:

  • A wide array of drugs are available for managing bleeding disorders.
  • Identifying the specific cause of a hemorrhagic event is paramount for selecting appropriate therapy.
  • Clinicians must consider the financial implications and cost-effectiveness of different treatment options.

Impact:

  • Facilitates rational prescribing of medications for hemorrhagic conditions.
  • Promotes evidence-based decision-making by integrating clinical efficacy with economic considerations.
  • Aims to optimize patient outcomes while managing healthcare resource utilization.

Related Experiment Videos